CD274 and cancer: We previously demonstrated that Sigma1 physically associates with PD-L1 and triggers its lysosomal degradation.40 Here, we asked whether the Sigma1 inhibitor, IPAG, would prevent nascent PD-L1 from maturing and progressing through the secretory pathway in cell lines from multiple types of cancers.